KELLI NOWAK: Open Payments
NPI 1255760443 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 55 payments from 8 companies in 2025. Trend: 2023 $851 · 2024 $874 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 17 | $240 |
| Exeltis, USA Inc. | 10 | $153 |
| Sage Therapeutics, LLC | 15 | $146 |
| Sumitomo Pharma America, Inc. | 5 | $103 |
| Astellas Pharma US Inc | 3 | $55 |
| SHIELD THERAPEUTICS INC | 2 | $52 |
| Hologic Sales and Service, LLC | 2 | $48 |
| MILLICENT US INC | 1 | $21 |
Products named: SLYND, ZURZUVAE, MYFEMBREE, Veozah, ACCRUFER, APTIMA, THINPREP 2000 PROCESSOR, FEMRING.
Industry payments across CA — which companies pay providers there.
